| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 155.283 | 152.778 | 259.573 | 289.203 | 349.241 | 311.950 | 583.951 | 747.833 | 992.398 | 1.138.242 |
| Total Income - EUR | 158.586 | 152.913 | 259.575 | 292.499 | 350.106 | 315.299 | 594.547 | 751.774 | 1.000.664 | 1.152.723 |
| Total Expenses - EUR | 131.824 | 151.294 | 240.517 | 278.363 | 316.361 | 297.343 | 506.178 | 642.100 | 855.623 | 1.015.988 |
| Gross Profit/Loss - EUR | 26.762 | 1.619 | 19.058 | 14.136 | 33.746 | 17.955 | 88.369 | 109.674 | 145.041 | 136.735 |
| Net Profit/Loss - EUR | 22.829 | 1.373 | 16.823 | 11.206 | 30.397 | 16.433 | 84.716 | 104.022 | 127.493 | 119.079 |
| Employees | 8 | 10 | 13 | 15 | 16 | 14 | 17 | 17 | 19 | 23 |
Check the financial reports for the company - Memorix Trial Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 9.734 | 15.882 | 61.823 | 78.149 | 120.197 | 108.772 | 162.366 | 180.355 | 209.056 | 257.485 |
| Current Assets | 26.523 | 21.854 | 21.585 | 38.799 | 59.528 | 44.015 | 107.674 | 186.982 | 251.324 | 264.285 |
| Inventories | 8.877 | 7.610 | 6.954 | 12.461 | 34.108 | 27.549 | 44.665 | 52.951 | 44.494 | 23.021 |
| Receivables | 5.283 | 4.256 | 9.208 | 14.119 | 10.233 | 6.433 | 7.942 | 25.615 | 52.767 | 26.132 |
| Cash | 12.363 | 9.988 | 5.423 | 12.218 | 15.188 | 10.033 | 55.067 | 108.416 | 154.063 | 215.133 |
| Shareholders Funds | 31.361 | 32.414 | 48.688 | 59.001 | 88.255 | 103.015 | 185.447 | 275.316 | 362.420 | 446.697 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.896 | 5.322 | 34.720 | 57.947 | 91.470 | 49.987 | 59.056 | 69.758 | 78.447 | 58.400 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 25.537 | 22.326 | 19.513 | 16.674 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5621 - 5621" | |||||||||
| CAEN Financial Year |
5621
|
|||||||||
Comments - Memorix Trial Srl